Safety Concerns
3 articles on Safety Concerns, written by Shotlee and medically reviewed for clinical accuracy.
RFK Jr. Misrepresents Ex-FDA Officials in Push to Lift Peptide Ban
Health Secretary RFK Jr. is pushing to lift the FDA's ban on 19 peptides used in compounding pharmacies, claiming the decision was illegal with no safety signals. But former FDA officials, including Janet Woodcock, say he misrepresents their views amid documented risks like immune reactions and trial fatalities. As demand surges via influencers, recent illnesses highlight the stakes in this regulatory battle.
6 min read
Wellness Awaits RFK Jr.'s FDA Move on Peptides
Health Secretary RFK Jr. hinted at FDA easing restrictions on popular peptides like BPC-157 and ipamorelin during a Joe Rogan podcast. Wellness fans hope for access from ethical suppliers, but experts warn of black market dangers. Discover the regulatory shift's potential impact on peptide therapy.
5 min read
FDA Expedited Drug Program Raises Safety Concerns for Obesity Meds
The FDA's Commissioner's National Priority Voucher program aims to approve drugs in as little as one month, including anti-obesity medications. Staff and experts raise alarms over skipped steps, legal risks, and safety issues, like patient deaths in trials. Traditional six-to-10-month reviews ensure rigorous safety checks for GLP-1 drugs.
4 min read